COCH Envoy Medical, Inc.

Nasdaq www.envoymedical.com


$ 0.90 $ -0.02 (-2.71 %)    

Wednesday, 15-Oct-2025 15:59:50 EDT
QQQ $ 602.75 $ -1.66 (-0.27 %)
DIA $ 462.75 $ -1.92 (-0.41 %)
SPY $ 665.38 $ -1.70 (-0.25 %)
TLT $ 90.69 $ -0.30 (-0.33 %)
GLD $ 387.40 $ 1.52 (0.39 %)
$ 0.9183
$ 0.92
$ 0.89 x 300
$ 0.95 x 123
$ 0.89 - $ 0.95
$ 0.74 - $ 3.09
1,218,909
na
19.64M
$ 0.24
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-31-2025 06-30-2025 10-Q
2 05-01-2025 03-31-2025 10-Q
3 03-28-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-12-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 04-01-2024 12-31-2023 10-K
8 11-17-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 04-03-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-16-2022 03-31-2022 10-Q
15 03-31-2022 12-31-2021 10-K
16 11-12-2021 09-30-2021 10-Q
17 08-18-2021 06-30-2021 10-Q
18 05-17-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 envoy-medical-announces-it-is-scaling-its-commercialization-planning-for-the-companys-breakthrough-investigational-acclaim-fully-implanted-cochlear-implant-as-pivotal-trial-progresses

The Company Begins Strategic Preparations To Support Anticipated Demand And Optimization Of The Acclaim® Fully Implanted Cochle...

 envoy-medical-secures-european-patent-for-fully-implanted-cochlear-system-strengthening-ip-ahead-of-acclaim-launch

Patent covers advanced signal processing for middle ear sensors, further advancing the Company's position in leveraging the...

 envoy-medical-issued-four-global-patents

The following patents are being issued to Envoy Medical:U.S. Patent No. 12,418,758 on September 16, 2025. The title is Programm...

 envoy-medical-reports-safety-milestone-in-pivotal-trial-for-fully-implanted-cochlear-implant-remains-on-track-for-fda-submission

No Serious Adverse Events or Unanticipated Device Effects Reported; Company Confirms Program Remains On TrackWhite Bear Lake, M...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION